Does ENFORTUMAB VEDOTIN Cause Malignant neoplasm progression? 166 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 166 reports of Malignant neoplasm progression have been filed in association with ENFORTUMAB VEDOTIN (PADCEV EJFV). This represents 11.7% of all adverse event reports for ENFORTUMAB VEDOTIN.
166
Reports of Malignant neoplasm progression with ENFORTUMAB VEDOTIN
11.7%
of all ENFORTUMAB VEDOTIN reports
70
Deaths
53
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ENFORTUMAB VEDOTIN?
Of the 166 reports, 70 (42.2%) resulted in death, 53 (31.9%) required hospitalization, and 11 (6.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENFORTUMAB VEDOTIN. However, 166 reports have been filed with the FAERS database.
What Other Side Effects Does ENFORTUMAB VEDOTIN Cause?
Rash (173)
Neuropathy peripheral (172)
Decreased appetite (106)
Diarrhoea (96)
Pruritus (83)
Alopecia (78)
Inappropriate schedule of product administration (73)
Pyrexia (70)
Hyperglycaemia (69)
Nausea (67)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ENFORTUMAB VEDOTIN Alternatives Have Lower Malignant neoplasm progression Risk?
ENFORTUMAB VEDOTIN vs ENFORTUMAB VEDOTIN-EJFV
ENFORTUMAB VEDOTIN vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV
ENFORTUMAB VEDOTIN vs ENFUVIRTIDE
ENFORTUMAB VEDOTIN vs ENOXAPARIN
ENFORTUMAB VEDOTIN vs ENOXAPARIN - WINTHROP